Metraipolis › archive › dc_b8f043ff73a5
Antibody-Drug Conjugates Targeting Resistance-Associated Signaling Pathways: Recent Advances and Future Perspectives — Europe PMC PMID:41977464
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41977464
- DOI
- 10.3390/ijms27073287
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T08:56:35.929Z
- SHA-256 of the archived text
be8d45a10187f5a0952d9f3a8eaa93d40cfffb81477d0a49d701c63a4fea51c2- Stable URL of this page
https://metraipolis.com/documento/dc_b8f043ff73a5
How to cite
Antibody-Drug Conjugates Targeting Resistance-Associated Signaling Pathways: Recent Advances and Future Perspectives — Europe PMC PMID:41977464 — Europe PMC (en), https://europepmc.org/article/MED/41977464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b8f043ff73a5 (Metraipolis archive dc_b8f043ff73a5, sha256 be8d45a10187f5a0952d9f3a8eaa93d40cfffb81477d0a49d701c63a4fea51c2)
BibTeX
@misc{dcb8f043ff73a5,
title = {Antibody-Drug Conjugates Targeting Resistance-Associated Signaling Pathways: Recent Advances and Future Perspectives — Europe PMC PMID:41977464},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41977464},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b8f043ff73a5; sha256 be8d45a10187f5a0952d9f3a8eaa93d40cfffb81477d0a49d701c63a4fea51c2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41977464. Agents can read the archived copy with the MCP tool read_document.